Global hematology HORIBA Medical is a global leader in hematology with presence in over 110 countries and more than 1000 employees, indicating a broad market reach and scalable sales opportunities for routine hematology analyzers and complementary diagnostics.

Strong installed base With over 300 000 laboratories equipped and a long-standing reputation in In Vitro Diagnostics, there is a robust installation base that can be leveraged for upsell of new analyzers, software upgrades, maintenance plans, and consumables.

Strategic partnerships Recent collaborations around inline Raman systems and biopharmaceutical manufacturing suggest opportunities to cross-sell advanced analytical technologies, real-time monitoring solutions, and co-developed systems to AI-enabled workflows for biopharma and healthcare customers.

Veterinary expansion The Yumivet veterinary diagnostics introduction signals a product diversification channel and potential cross-selling opportunities to veterinary clinics and multi-species labs seeking rapid hematology testing capabilities.

Funding-ready profile With a revenue range of 1–10 million and a large multinational peer group, positioning HORIBA Medical as a mid-market innovator enables targeted outreach to hospitals, labs, and regional distributors looking for scalable, modern hematology solutions with service and support.